Resumen
Background: There is limited research on whether physical activity (PA) in early childhood is associated with the timing of pubertal events in girls. Methods: We used data collected over 2011–16 from the LEGACY Girls Study (n = 984; primarily aged 6–13 years at study enrolment), a multicentre North American cohort enriched for girls with a breast cancer family history (BCFH), to evaluate if PA is associated with age at thelarche, pubarche and menarche. Maternal-reported questionnaire data measured puberty outcomes, PA in early childhood (ages 3–5 years) and total metabolic equivalents of organized PA in middle childhood (ages 7–9 years). We used interval-censored Weibull parametric survival regression models with age as the time scale and adjusted for sociodemographic factors, and we tested for effect modification by BCFH. We used inverse odds weighting to test for mediation by body mass index-for-age z-score (BMIZ) measured at study enrolment. Results: Being highly active vs inactive in early childhood was associated with later thelarche in girls with a BCFH [adjusted hazard ratio (aHR) = 0.39, 95% CI = 0.26–0.59), but not in girls without a BCFH. In all girls, irrespective of BCFH, being in the highest vs lowest quartile of organized PA in middle childhood was associated with later menarche (aHR = 0.70, 95% CI = 0.50–0.97). These associations remained after accounting for potential mediation by BMIZ. Conclusion: This study provides new data that PA in early childhood may be associated with later thelarche in girls with a BCFH, also further supporting an overall association between PA in middle childhood and later menarche.
Idioma original | English |
---|---|
Número de artículo | dyad193 |
Publicación | International Journal of Epidemiology |
Volumen | 53 |
N.º | 1 |
DOI | |
Estado | Published - feb. 1 2024 |
Financiación
This work was supported by the National Cancer Institute (NCI) at the National Institutes of Health (grants K99CA263024 to R.D.K.; CA138638 to E.M.J.; CA138819 to M.B.D.; CA138822 to M.B.T.; and CA138844 to I.L.A.). I.L.A. holds the Anne and Max Tanenbaum Chair in Molecular Medicine at Mount Sinai Hospital and the University of Toronto. Acknowledgements This work was supported by the National Cancer Institute (NCI) at the National Institutes of Health (grants K99CA263024 to R.D.K.; CA138638 to E.M.J.; CA138819 to M.B.D.; CA138822 to M.B.T.; and CA138844 to I.L.A.). I.L.A. holds the Anne and Max Tanenbaum Chair in Molecular Medicine at Mount Sinai Hospital and the University of Toronto. The authors thank the LEGACY girls and family members for their contributions to the study, and our colleagues at the participating family genetics and oncology clinics. R.K. has full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Financiadores | Número del financiador |
---|---|
National Institutes of Health | CA138819, K99CA263024, CA138638, CA138822, CA138844 |
National Cancer Institute | |
University of Toronto |
ASJC Scopus Subject Areas
- Epidemiology